Business · Companies · 2 hrs ago
Ems-Chemie shares reach a four-year high as investors weigh growth prospects
Ems-Chemie shares closed at 867 Swiss francs on Friday, their highest level in four years.
The stock has gained almost 60% this year after falling to just over 518 francs last November.
The Swiss specialty chemicals company makes more than 60% of its sales from the auto industry, and its sales drive launched in 2023 is bringing in profitable new business, especially in China.
In the first half of 2026, net profit rose 2.5% to 259 million francs, and the company raised its outlook for the year.
But the shares now trade at more than 40 times the company’s earnings over the past year, and the average analyst price target is about 738 francs, well below the current price.
Analysts also point to the possibility that unusually high profit margins may not last.
Investors are expected to watch the company’s third-quarter figures on October 22 and its annual results in February 2027, along with demand from the auto industry, especially in China.
Ems-Chemie shares closed at 867 Swiss francs on Friday, after reaching 869 francs during the day, their highest level in four years.
The shares have gained almost 60% since the start of the year, recovering from a six-year low of just over 518 francs last November.
Investors have responded to improved half-year results and an upgraded outlook, alongside profitable new business from a sales drive launched in 2023.
Analysts caution that the shares are expensive, and the average 12-month price target is around 738 francs, more than 15% below the current price.
Investors are expected to watch the company’s third-quarter figures on October 22 and its business in China.
- Who
- Ems-Chemie and its investors.
- What
- The shares reached a four-year high after a strong recovery and gains of almost 60% since the start of the year.
- When
- The shares closed at 867 francs on Friday, October 9, 2026, after reaching 869 francs during the day.
- Where
- Switzerland; Ems-Chemie’s shares are discussed in the article.
- Why
- Improved half-year results, an upgraded outlook and profitable new business from the company’s sales drive supported the shares. The article also cites technical factors and investor expectations.
Technical and growth case
Cautious analyst view
Share outlook
Technical and growth case
A sustained move above resistance at 870 to 890 francs could open a path toward 950 to 1,000 francs.
Cautious analyst view
CFRA’s 820-franc target is below the current share price, while the average target is around 738 francs.
Valuation and profits
Technical and growth case
The company raised its outlook, and its sales drive is bringing increasingly profitable new business.
Cautious analyst view
Analysts cite historically high valuation; Berenberg says high margins reflect supply bottlenecks and wider spreads and that profitability is near its peak.
No direct quotes in the coverage so far.
Ems-Chemie shares fell to just over 518 francs, a six-year low.
The company released provisional half-year figures, and its shares rose by almost 5% that day.
Ems-Chemie reported final half-year results and raised its full-year outlook.
The shares closed at 867 francs after reaching 869 francs, a four-year high.
The company is due to report its third-quarter figures.
- Friday closing price
- 867 Swiss francs
- Intraday high
- 869 Swiss francs
- Gain since start of 2026
- Almost 60%
- Half-year net profit
- 259 million Swiss francs, up 2.5%
- Half-year operating result
- 309 million Swiss francs, up 4.4%
- Average 12-month price target
- Around 738 Swiss francs
Sources
Related news
Investor sees value in overlooked US stocks and regional banks
BNP Paribas targets €100 billion in ETF inflows by 2030
Nicolai Nussbaumer joins Alpen Partners after 22 years at Rahn+Bodmer
ZKB faces claims of abrupt staff changes in its direct banking unit
Ascend plans SIX listing through merger with EvoNext
Adel Abdel-Latif seeks $7.9 million from Dubai investment firm
High oil prices put pressure on several Swiss-listed companies
Lastminute appoints Ludovic Boisseau as finance chief from November 16
Centiel cuts 2026 forecast as US deliveries move to 2027
Swiss SMI rises for the week after a volatile trading period
S&P gives Zurich a negative financial outlook while keeping its top rating
